Sean Bohen
Fortuna: 2 M $ al 30/09/2026
Fortuna: 2 M $ al 30/09/2026
Dr. Sean P.
Bohen is a President, Chief Executive Officer & Director at Olema Pharmaceuticals, Inc. He is on the Board of Directors at Gyroscope Therapeutics Ltd., Olema Pharmaceuticals, Inc. and AltruBio, Inc. Dr. Bohen was previously employed as a Non-Executive Director by Gyroscope Therapeutics Holdings Plc, a Chief Medical Officer & Executive Vice President by AstraZeneca PLC, a Senior Vice President-Early Development by Genentech, Inc., and an Associate by Howard Hughes Medical Institute, Inc. He received his undergraduate degree from the University of Wisconsin and a doctorate degree from The University of California, San Francisco.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 23/04/2026 | 237.650 ( 0,27 % ) | 2 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Director Ejecutivo | 01/09/2020 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Director/Miembro de la Junta | 11/09/2020 |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Director/Miembro de la Junta | 01/08/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Director/Miembro de la Junta | 17/02/2022 |
| ASTRAZENECA PLC | Director Técnico/Científico/I+D | 14/01/2019 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/07/2015 |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | 01/01/2003 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
Gyroscope Therapeutics Holdings Plc
Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.